Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Incorporated reported the voting results from its 2026 annual meeting of stockholders. Holders of common stock elected all 11 director nominees to the Board of Directors for one-year terms. Stockholders also approved, on an advisory basis, executive compensation and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Ingredion Inc senior vice president David Eric Seip reported a compensation-related award of phantom stock. On May 15, 2026, he acquired 17.019 phantom stock units tied to the company’s common stock at a reference price of $102.62 per share, bringing his total phantom stock holdings to 13,183.2411 units.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and CIO Michael J. Leonard received a grant of 33.286 phantom stock units on May 15, 2026 under a Non-Qualified Deferred Compensation Plan. Each phantom unit represents the right to receive one share of common stock, bringing his total phantom stock holdings to 1,615.457 units.
Ingredion Incorporated has disclosed that it made a non-binding, indicative all-cash offer to acquire Tate & Lyle PLC at a price of 595 pence per Tate & Lyle share. The proposal is at an early stage and does not constitute a firm intention to make an offer.
Under the possible terms, Tate & Lyle would be allowed to pay a final dividend of up to 13 pence per share for the year ended 31 March 2026 and an interim dividend of up to 7 pence per share for the six months to 30 September 2026. Ingredion is conducting due diligence and engaging in discussions, and has until 5:00 pm (London time) on 11 June 2026 to announce a firm offer or state it does not intend to proceed, subject to any extension granted by the UK Takeover Panel.
Ingredion reported weaker results for Q1 2026, with net income attributable to the company falling to $142 million from $197 million a year earlier. Net sales slipped 1% to $1.79 billion, while gross profit declined to $401 million and gross margin narrowed from 26% to 22% due mainly to lower volumes and fixed-cost absorption.
Operating income dropped 26% to $203 million as cost of sales rose and operating expenses increased 4% to $200 million on higher employee costs. Segment performance was mixed: Texture & Healthful Solutions and Latin America grew sales modestly, but U.S./Canada net sales fell 9% and operating income there dropped sharply to $34 million, reflecting production challenges at the Argo facility and softer volumes.
Cash from operating activities decreased to $33 million from $77 million, while capital spending rose to $110 million. The company highlighted strong liquidity of $3.8 billion and total debt of $1.8 billion. Subsequent to quarter end, Ingredion approved a plan to cease operations at its Cabo, Brazil facility and disclosed an Argo “thermal event,” expecting about $43 million of related pre-tax charges and roughly $20 million of direct costs, largely in Q2 2026.
Ingredion Inc executive Robert A. Ritchie reported a routine tax-withholding share disposition related to vesting equity awards. On this Form 4, 842 shares of common stock were withheld at $110.43 per share to cover taxes when 2,880 restricted stock units and 241.005 RSUs from deemed dividend reinvestments vested. Following this event, he directly holds 31,177.7458 common shares.
Ingredion Incorporated plans to cease operations at its Cabo, Brazil manufacturing facility as of June 30, 2026, and expects to sell the facility and underlying real property. The company anticipates approximately $43 million in pre-tax, non-recurring charges tied to this exit plan.
About $36 million of these charges are expected to be non-cash impairment charges related to fixed asset and inventory write-downs, with about $7 million in expected cash expenditures for employee-related, severance, and other termination costs. Most charges are expected in the second quarter of 2026, with remaining amounts through the first quarter of 2027.
Ingredion Incorporated reported weaker first quarter 2026 results, with earnings and operating profit declining year over year and full-year guidance reduced. Net sales were $1.792 billion, down 1% from $1.813 billion in the first quarter 2025 as softer demand and less favorable mix in Food & Industrial Ingredients–U.S./Canada more than offset growth in other segments.
Reported diluted EPS fell to $2.22 from $3.00, while adjusted EPS declined to $2.34 from $2.97, reflecting lower operating income and higher restructuring costs. Reported operating income dropped to $203 million from $276 million, and adjusted operating income decreased to $212 million from $273 million, driven mainly by higher costs and lower volumes in the U.S./Canada business, including production challenges at the Argo facility.
Texture & Healthful Solutions delivered continued volume growth, with operating income of $100 million, slightly above the prior year, and Food & Industrial Ingredients–LATAM posted operating income of $115 million, down from $127 million. All Other generated operating income of $3 million, reflecting improvements in plant-based protein.
The company updated its full-year 2026 outlook, now expecting reported EPS of $9.60–$10.30 and adjusted EPS of $10.45–$11.15. It now anticipates full-year net sales to be flat to up low single digits, reported operating income to be down high single digits, and adjusted operating income to be flat to down low single digits. For full-year 2026, Ingredion expects cash from operations of $725–$825 million and capital expenditures of $400–$440 million.
Ingredion Inc senior vice president David Eric Seip reported a compensation-related grant of phantom stock on April 30, 2026. He acquired 15.63 phantom stock units under the company’s Non-Qualified Deferred Compensation Plan, with each unit representing the right to receive one share of common stock.
Following this grant and prior allocations, Seip now has a total of 13,166.2221 phantom stock units credited under the plan, based on the issuer’s closing share price on April 30, 2026 and including units accumulated through dividend reinvestment.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and chief information officer Michael J. Leonard received a grant of 30.569 phantom stock units on April 30, 2026. These units were credited under the company’s Non-Qualified Deferred Compensation Plan based on the closing price of Ingredion common stock on that date.
Each phantom stock unit represents the right to receive one share of common stock in the future, and the total phantom stock balance for Leonard after this grant is 1,582.171 units, including amounts accumulated through dividend reinvestment.